SCHEMBL4060496

SCHEMBL4060496

Cc1cc(C(=O)C2CC2)cc2oc(=O)[nH]c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP2D6 P10635 1/20 0.37
CREBBP Q92793 1/20 0.37
SMYD3 Q9H7B4 2/20 0.36
EPHX2 P34913 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GRM5 P41594 3/20 0.34
SYK P43405 1/20 0.34
NOS1 P29475 2/20 0.33
NOS3 P29474 1/20 0.33
NOS2 P35228 1/20 0.33
PKM P14618 1/20 0.32
GRM1 Q13255 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL3961557 0.97 SMN1; SMN2 (0.36) MEN1KMT2ACYP2D6CREBBPSMYD3
SCHEMBL3961553 0.81 KMO (0.39) CREBBPSMYD3EPHX2ALDH1A1KDM4E
SCHEMBL13907765 0.81 KMO (0.39) CREBBPSMYD3EPHX2ALDH1A1KDM4E
SCHEMBL1285709 0.80 CREBBP (0.41) CREBBPEPHX2ALDH1A1KDM4EGRM5
SCHEMBL1286048 0.80 TTR (0.41) CREBBPEPHX2ALDH1A1KDM4EGRM5
SCHEMBL13907948 0.79 KDM4E (0.41) MEN1KMT2ACREBBPEPHX2ALDH1A1
SCHEMBL13907983 0.77 MEN1 (0.34) MEN1KMT2ACREBBPEPHX2ALDH1A1
SCHEMBL1285701 0.77 CREBBP (0.58) MEN1KMT2ACREBBPEPHX2ALDH1A1
SCHEMBL3652835 0.74 CREBBP (0.37) CREBBPSMYD3EPHX2ALDH1A1KDM4E
SCHEMBL1286027 0.73 TTR (0.36) CREBBPEPHX2ALDH1A1KDM4EGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034029-A2 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-19 WO disclosed